Home > Boards > US Listed > Medical - Healthcare > China Cord Blood Corp (CO)

This Amendment No. 3 ( “Amendment”) relates to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
locksflooring Member Profile
 
Followed By 126
Posts 30,911
Boards Moderated 0
Alias Born 12/21/08
160x600 placeholder
The Committee for China Cord Fairness Announces Support From The Two Leading Proxy Advisory Firms for Proposals Seeking Minor... PR Newswire (US) - 10/16/2019 9:00:00 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 9/23/2019 8:50:38 AM
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019 PR Newswire (US) - 9/20/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/27/2019 4:25:21 PM
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 PR Newswire (US) - 8/27/2019 4:16:00 PM
The Committee for China Cord Fairness Launches Consent Solicitation at Global Cord Blood Corporation PR Newswire (US) - 8/27/2019 9:00:00 AM
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results PR Newswire (US) - 8/21/2019 7:00:00 AM
Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) Edgar (US Regulatory) - 8/14/2019 6:35:20 AM
Global Cord Blood Corporation (NYSE: CO) Urged To Explain Management Compensation in Third Letter From Shareholder Group PR Newswire (US) - 8/7/2019 9:00:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 7/23/2019 4:19:02 PM
Global Cord Blood Corporation Files Its Annual Report on Form 20-F PR Newswire (US) - 7/23/2019 4:16:00 PM
Global Cord Blood Corporation (NYSE: CO) Urged in Second Letter From Shareholder Group to Protect Minority Shareholders PR Newswire (US) - 7/17/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/18/2019 4:34:04 PM
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019 PR Newswire (US) - 6/18/2019 4:16:00 PM
Shareholder of Global Cord Blood Corporation (NYSE: CO) Hires Global Law Firm, The Seiden Group, to Help Investigate and Enfo... PR Newswire (US) - 6/17/2019 10:56:00 PM
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results PR Newswire (US) - 6/11/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 6:12:14 AM
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal PR Newswire (US) - 6/6/2019 6:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 8:28:45 AM
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company PR Newswire (US) - 6/4/2019 8:16:00 AM
Global Cord Blood Corporation Raised Subscription Fee PR Newswire (US) - 4/1/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/25/2019 4:26:57 PM
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019 PR Newswire (US) - 2/25/2019 4:16:00 PM
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results PR Newswire (US) - 2/19/2019 6:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 6:05:33 AM
locksflooring   Wednesday, 04/18/12 08:54:15 PM
Re: None
Post # of 429 
This Amendment No. 3 ( “Amendment”) relates to the ordinary shares, par value $0.0001 (the “Ordinary Shares”), of China Cord Blood Corporation, a Cayman Islands corporation (the “Issuer” or “CCBC”). This Amendment is being filed jointly by Golden Meditech Stem Cells (BVI) Company Limited, a British Virgin Islands company (“GM Stem Cells”), and Golden Meditech Holdings Limited, a Cayman Islands company (“Golden Meditech” and, collectively with GM Stem Cells, the “Reporting Persons”).

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist